{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:23:32Z","timestamp":1789179812593,"version":"build-2803163510"},"reference-count":30,"publisher":"Pharmaceutical Society of Japan","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2018]]},"DOI":"10.1248\/bpb.b17-00680","type":"journal-article","created":{"date-parts":[[2017,11,26]],"date-time":"2017-11-26T22:16:35Z","timestamp":1511734595000},"page":"277-280","source":"Crossref","is-referenced-by-count":9,"title":["The Effect of Ethanol on the Hydrolysis of Ester-Type Drugs by Human Serum Albumin"],"prefix":"10.1248","volume":"41","author":[{"given":"Akitoshi","family":"Tatsumi","sequence":"first","affiliation":[{"name":"Educational Center for Clinical Pharmacy, Kobe Pharmaceutical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiyo","family":"Inoue","sequence":"additional","affiliation":[{"name":"Educational Center for Clinical Pharmacy, Kobe Pharmaceutical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuneo","family":"Hamaguchi","sequence":"additional","affiliation":[{"name":"Educational Center for Clinical Pharmacy, Kobe Pharmaceutical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seigo","family":"Iwakawa","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Kobe Pharmaceutical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Carter DC, Ho JX. Structure of serum albumin. Adv. Protein Chem.<\/i>, 45<\/b>, 153\u2013203 (1994).","DOI":"10.1016\/S0065-3233(08)60640-3"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) He XM, Carter DC. Atomic structure and chemistry of human serum albumin. Nature<\/i>, 358<\/b>, 209\u2013215 (1992).","DOI":"10.1038\/358209a0"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Sudlow G, Birkett DJ, Wade DN. The characterization of two specific drug binding sites on human serum albumin. Mol. Pharmacol.<\/i>, 11<\/b>, 824\u2013832 (1975).","DOI":"10.1016\/S0026-895X(25)10691-3"},{"key":"4","unstructured":"4) Yang F, Bian C, Zhu L, Zhao G, Huang Z, Huang M. Effect of human serum albumin on drug metabolism: structural evidence of esterase activity of human serum albumin. J. Struct. Biol.<\/i>, 157<\/b>, 348\u2013355 (2007)."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Tsuda Y, Tsunoi T, Watanabe N, Ishida M, Yamada H, Itoh T. Stereoselective binding and degradation of sulbenicillin in the presence of human serum albumin. Chirality<\/i>, 13<\/b>, 236\u2013243 (2001).","DOI":"10.1002\/chir.1025"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Williams AM, Dickinson RG. Studies on the reactivity of acyl glucuronides\u2014VI. Modulation of reversible and covalent interaction of diflunisal acyl glucuronide and its isomers with human plasma protein in vitro.<\/i> Biochem. Pharmacol.<\/i>, 47<\/b>, 457\u2013467 (1994).","DOI":"10.1016\/0006-2952(94)90176-7"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Watanabe H, Tanase S, Nakajou K, Maruyama T, Kragh-Hansen U, Otagiri M. Role of arg-410 and tyr-411 in human serum albumin for ligand binding and esterase-like activity. Biochem. J.<\/i>, 349<\/b>, 813\u2013819 (2000).","DOI":"10.1042\/bj3490813"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Means GE, Bender ML. Acetylation of human serum albumin by p<\/i>-nitrophenyl acetate. Biochemistry<\/i>, 14<\/b>, 4989\u20134994 (1975).","DOI":"10.1021\/bi00693a031"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Ikeda K, Kurono Y, Ozeki Y, Yotsuyanagi T. Effects of drug bindings on esterase activity of human serum albumin. Dissociation constants of the complexes between the protein and drugs such as N<\/i>-arylanthranilic acids, coumarin derivatives and prostaglandins. Chem. Pharm. Bull.<\/i>, 27<\/b>, 80\u201387 (1979).","DOI":"10.1248\/cpb.27.80"},{"key":"10","unstructured":"10) Lockridge O, Xue W, Gaydess A, Grigoryan H, Ding SJ, Schopfer LM, Hinrichs SH, Masson P. Pseudo-esterase activity of human albumin: slow turnover on tyrosine 411 and stable acetylation of 82 residues including 59 lysines. J. Biol. Chem.<\/i>, 283<\/b>, 22582\u201322590 (2008)."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Kurono Y, Kushida I, Tanaka H, Ikeda K. Esterase-like activity of human serum albumin. VIII. Reaction with amino acid p<\/i>-nitrophenyl esters. Chem. Pharm. Bull.<\/i>, 40<\/b>, 2169\u20132172 (1992).","DOI":"10.1248\/cpb.40.2169"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Georges H, Presle N, Buronfosse T, Fournel-Gigleux S, Netter P, Magdalou J, Lapicque F. In vitro<\/i> stereoselective degradation of carprofen glucuronide by human serum albumin. Characterization of sites and reactive amino acids. Chirality<\/i>, 12<\/b>, 53\u201362 (2000).","DOI":"10.1002\/(SICI)1520-636X(2000)12:2<53::AID-CHIR1>3.0.CO;2-1"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Ma SF, Anraku M, Iwao Y, Yamasaki K, Kragh-Hansen U, Yamaotsu N, Hirono S, Ikeda T, Otagiri M. Hydrolysis of angiotensin II receptor blocker prodrug olmesartan medoxomil by human serum albumin and identification of its catalytic active sites. Drug Metab. Dispos.<\/i>, 33<\/b>, 1911\u20131919 (2005).","DOI":"10.1124\/dmd.105.006163"},{"key":"14","unstructured":"14) Weathermon R, Crabb DW. Alcohol and medication interactions. Alcohol Res. Health<\/i>, 23<\/b>, 40\u201354 (1999)."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Ha CE, Petersen CE, Park DS, Harohalli K, Bhagavan NV. Investigations of the effects of ethanol on warfarin binding to human serum albumin. J. Biomed. Sci.<\/i>, 7<\/b>, 114\u2013121 (2000).","DOI":"10.1007\/BF02256617"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Michnik A, Drzazga Z. Effect of ethanol on the thermal stability of human serum albumin. J. Therm. Anal. Calorim.<\/i>, 88<\/b>, 449\u2013454 (2007).","DOI":"10.1007\/s10973-006-8072-6"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Tatsumi A, Kadobayashi M, Iwakawa S. Effect of ethanol on the binding of warfarin enantiomers to human serum albumin. Biol. Pharm. Bull.<\/i>, 30<\/b>, 826\u2013829 (2007).","DOI":"10.1248\/bpb.30.826"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Tatsumi A, Ikegami Y, Morii R, Sugiyama M, Kadobayashi M, Iwakawa S. Effect of ethanol on S<\/i>-warfarin and diclofenac metabolism by recombinant human CYP2C9.1. Biol. Pharm. Bull.<\/i>, 32<\/b>, 517\u2013519 (2009).","DOI":"10.1248\/bpb.32.517"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Tatsumi A, Okada M, Inagaki Y, Inoue S, Hamaguchi T, Iwakawa S. Differences in esterase activity to aspirin and p<\/i>-nitrophenyl acetate among human serum albumin preparations. Biol. Pharm. Bull.<\/i>, 39<\/b>, 1364\u20131369 (2016).","DOI":"10.1248\/bpb.b16-00011"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Fogel J, Epstein P, Chen P. Simultaneous high-performance liquid chromatography assay of acetylsalicylic acid and salicylic acid in film-coated aspirin tablets. J. Chromatogr.<\/i>, 317<\/b>, 507\u2013511 (1984).","DOI":"10.1016\/S0021-9673(01)91690-5"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Phuangsawai O, Hannongbua S, Gleeson MP. Elucidating the origin of the esterase activity of human serum albumin using QM\/MM calculations. J. Phys. Chem. B<\/i>, 118<\/b>, 11886\u201311894 (2014).","DOI":"10.1021\/jp506629y"},{"key":"22","unstructured":"22) D\u00edaz N, Su\u00e1rez D, Sordo TL, Merz KM Jr. Molecular dynamics study of the IIA binding site in human serum albumin: influence of the protonation state of Lys195 and Lys199. J. Med. Chem.<\/i>, 44<\/b>, 250\u2013260 (2001)."},{"key":"23","unstructured":"23) Petitpas I, Bhattacharya AA, Twine S, East M, Curry S. Crystal structure analysis of warfarin binding to human serum albumin: anatomy of drug site I. J. Biol. Chem.<\/i>, 276<\/b>, 22804\u201322809 (2001)."},{"key":"24","unstructured":"24) Curry S, Brick P, Franks NP. Fatty acid binding to human serum albumin: new insights from crystallographic studies. Biochim. Biophys. Acta<\/i>, 1441<\/b>, 131\u2013140 (1999)."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Vorum H, Honor\u00e9 B. Influence of fatty acids on the binding of warfarin and phenprocoumon to human serum albumin with relation to anticoagulant therapy. J. Pharm. Pharmacol.<\/i>, 48<\/b>, 870\u2013875 (1996).","DOI":"10.1111\/j.2042-7158.1996.tb03990.x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Bojko B, Su\u0142kowska A, Maciazek M, R\u00f3wnicka J, Njau F, Su\u0142kowski WW. Changes of serum albumin affinity for aspirin induced by fatty acid. Int. J. Biol. Macromol.<\/i>, 42<\/b>, 314\u2013323 (2008).","DOI":"10.1016\/j.ijbiomac.2007.11.002"},{"key":"27","unstructured":"27) Avdulov NA, Chochina SV, Daragan VA, Schroeder F, Mayo KH, Wood WG. Direct binding of ethanol to bovine serum albumin: a fluorescent and 13<\/sup>C-NMR multiplet relaxation study. Biochemistry<\/i>, 35<\/b>, 340\u2013347 (1996)."},{"key":"28","unstructured":"28) Sakurai Y, Ma SF, Watanabe H, Yamaotsu N, Hirono S, Kurono Y, Kragh-Hansen U, Otagiri M. Esterase-like activity of serum albumin: characterization of its structural chemistry using p<\/i>-nitrophenyl esters as substrates. Pharm. Res.<\/i>, 21<\/b>, 285\u2013292 (2004)."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Kragh-Hansen U. Molecular and practical aspects of the enzymatic properties of human serum albumin and of albumin\u2013ligand complexes. Biochim. Biophys. Acta<\/i>, 1830<\/b>, 5535\u20135544 (2013).","DOI":"10.1016\/j.bbagen.2013.03.015"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Lin SY, Wei YS, Li MJ, Wang SL. Effect of ethanol or\/and captopril on the secondary structure of human serum albumin before and after protein binding. Eur. J. Pharm. Biopharm.<\/i>, 57<\/b>, 457\u2013464 (2004).","DOI":"10.1016\/j.ejpb.2004.02.005"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/41\/2\/41_b17-00680\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T14:28:31Z","timestamp":1751034511000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/41\/2\/41_b17-00680\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b17-00680","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}